A team of Memorial Sloan Kettering Cancer Center (MSK) researchers have made an important finding about why genetically ...

Senhwa Biosciences begins patient dosing in NCI-sponsored pilot study of Pidnarulex pharmacodynamics in patients with advanced solid tumours: Taipei, Taiwan Thursday, July 17, 202 ...

Learn more about the research of Mayo Clinic's Gene Editing and Cellular Engineering Laboratory led by David (Chun-Wei) D.

These findings highlight the dual roles of antioxidants in cancer. Their impact depends on cancer type, stage, and genetic ...

Scientists at The Wistar Institute have discovered that a class of FDA-approved cancer drugs known as PARP1 inhibitors can ...

Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In ...

HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule ...

In conclusion, our present data revealed that c-Myc expression correlated with PD-L1 expression in pancreatic cancer and may serve as prognostic predictors clinically, indicating that restrainting ...

Recently, MYC has been shown to serve as a direct regulator of ribosome biogenesis and therefore coordinates protein synthesis. Could the regulation of ribosome biogenesis by MYC be necessary for ...

Researchers at KAIST in South Korea have discovered a new way to treat cancer. They can reprogram cancer cells to become normal cells. The technique u ...